Mark A. Halloran

870 total citations · 1 hit paper
8 papers, 673 citations indexed

About

Mark A. Halloran is a scholar working on Neurology, Cell Biology and Pharmacology. According to data from OpenAlex, Mark A. Halloran has authored 8 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Neurology, 3 papers in Cell Biology and 2 papers in Pharmacology. Recurrent topics in Mark A. Halloran's work include Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Mark A. Halloran is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (5 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). Mark A. Halloran collaborates with scholars based in Australia. Mark A. Halloran's co-authors include Julie D. Atkin, Kai Y. Soo, Manal A. Farg, Vinod Sundaramoorthy, Sonam Parakh, Anna E. King, Ian P. Blair, Shu Yang, Paul A. Gleeson and Rachel A.K. Atkinson and has published in prestigious journals such as Journal of Neurochemistry, Human Molecular Genetics and Cellular and Molecular Life Sciences.

In The Last Decade

Mark A. Halloran

8 papers receiving 658 citations

Hit Papers

C9ORF72, implicated in amytrophic lateral sclerosis and f... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Halloran Australia 6 464 250 207 154 125 8 673
Rachel A.K. Atkinson Australia 10 408 0.9× 236 0.9× 198 1.0× 72 0.5× 166 1.3× 16 638
Han-Jou Chen United Kingdom 8 528 1.1× 422 1.7× 259 1.3× 138 0.9× 103 0.8× 10 765
Christopher P Webster United Kingdom 10 370 0.8× 221 0.9× 162 0.8× 90 0.6× 108 0.9× 12 579
Hazel Urwin United Kingdom 5 485 1.0× 333 1.3× 206 1.0× 143 0.9× 202 1.6× 5 712
P. M. Andersen Sweden 7 649 1.4× 227 0.9× 318 1.5× 76 0.5× 221 1.8× 9 804
Valeria Gerbino Italy 9 363 0.8× 272 1.1× 231 1.1× 47 0.3× 57 0.5× 10 562
Nathaniel Safren United States 12 312 0.7× 265 1.1× 115 0.6× 99 0.6× 76 0.6× 17 493
Zongbing Hao China 12 257 0.6× 228 0.9× 98 0.5× 54 0.4× 96 0.8× 18 530
Joshua D. Kidd United States 9 356 0.8× 166 0.7× 167 0.8× 51 0.3× 75 0.6× 11 504
Amanda M. Gleixner United States 15 300 0.6× 492 2.0× 159 0.8× 72 0.5× 72 0.6× 20 714

Countries citing papers authored by Mark A. Halloran

Since Specialization
Citations

This map shows the geographic impact of Mark A. Halloran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Halloran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Halloran more than expected).

Fields of papers citing papers by Mark A. Halloran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Halloran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Halloran. The network helps show where Mark A. Halloran may publish in the future.

Co-authorship network of co-authors of Mark A. Halloran

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Halloran. A scholar is included among the top collaborators of Mark A. Halloran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Halloran. Mark A. Halloran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Halloran, Mark A., Audrey Ragagnin, Marta Vidal, et al.. (2019). Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress. Cellular and Molecular Life Sciences. 77(19). 3859–3873. 28 indexed citations
2.
Soo, Kai Y., Mark A. Halloran, Vinod Sundaramoorthy, et al.. (2015). Rab1-dependent ER–Golgi transport dysfunction is a common pathogenic mechanism in SOD1, TDP-43 and FUS-associated ALS. Acta Neuropathologica. 130(5). 679–697. 89 indexed citations
3.
Farg, Manal A., Vinod Sundaramoorthy, Shu Yang, et al.. (2014). C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Human Molecular Genetics. 23(13). 3579–3595. 377 indexed citations breakdown →
4.
Atkin, Julie D., Manal A. Farg, Adam K. Walker, et al.. (2013). Mutant SOD1 inhibits ER‐Golgi transport in amyotrophic lateral sclerosis. Journal of Neurochemistry. 129(1). 190–204. 56 indexed citations
5.
Parakh, Sonam, Damian M. S. Spencer, Mark A. Halloran, Kai Y. Soo, & Julie D. Atkin. (2013). Redox Regulation in Amyotrophic Lateral Sclerosis. Oxidative Medicine and Cellular Longevity. 2013. 1–12. 66 indexed citations
6.
Halloran, Mark A., Sonam Parakh, & Julie D. Atkin. (2013). The Role of S-Nitrosylation and S-Glutathionylation of Protein Disulphide Isomerase in Protein Misfolding and Neurodegeneration. International Journal of Cell Biology. 2013. 1–15. 53 indexed citations
7.
Halloran, Mark A., et al.. (2011). Red wine alters the glucose-insulin relationship when consumed alone after a meal. 19(1). 1–9. 2 indexed citations
8.
Halloran, Mark A., et al.. (2010). Consuming a small-moderate dose of red wine alone can alter the glucose–insulin relationship. Canadian Journal of Physiology and Pharmacology. 88(12). 1147–1156. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026